Papoutsaki M - Search Results

1

Adalimumab for the treatment of severe psoriasis and psoriatic arthritis.

Papoutsaki M, Costanzo A, Chimenti MS, Chimenti S. Papoutsaki M, et al. Expert Opin Biol Ther. 2008 Mar;8(3):363-70. doi: 10.1517/14712598.8.3.363. Expert Opin Biol Ther. 2008. PMID: 18294106 Review.

2

Efficacy of efalizumab in psoriasis patients previously treated with tumour necrosis factor blockers.

Costanzo A, Talamonti M, Botti E, Spallone G, Papoutsaki M, Chimenti S. Costanzo A, et al. Among authors: papoutsaki m. Dermatology. 2009;219(1):48-53. doi: 10.1159/000213758. Epub 2009 Apr 16. Dermatology. 2009. PMID: 19372639

3

The impact of methodological approaches for presenting long-term clinical data on estimates of efficacy in psoriasis illustrated by three-year treatment data on infliximab.

Papoutsaki M, Talamonti M, Giunta A, Costanzo A, Ruzzetti M, Teoli M, Chimenti S. Papoutsaki M, et al. Dermatology. 2010;221 Suppl 1:43-7. doi: 10.1159/000316184. Epub 2010 Aug 9. Dermatology. 2010. PMID: 20733314

4

Adalimumab for severe psoriasis and psoriatic arthritis: an open-label study in 30 patients previously treated with other biologics.

Papoutsaki M, Chimenti MS, Costanzo A, Talamonti M, Zangrilli A, Giunta A, Bianchi L, Chimenti S. Papoutsaki M, et al. J Am Acad Dermatol. 2007 Aug;57(2):269-75. doi: 10.1016/j.jaad.2006.12.003. Epub 2007 Jun 18. J Am Acad Dermatol. 2007. PMID: 17574299 Clinical Trial.

5

Long-term efficacy of adalimumab in generalized pustular psoriasis.

Zangrilli A, Papoutsaki M, Talamonti M, Chimenti S. Zangrilli A, et al. Among authors: papoutsaki m. J Dermatolog Treat. 2008;19(3):185-7. doi: 10.1080/09546630701759587. J Dermatolog Treat. 2008. PMID: 18569276 Free article.

6

Efficacy of short-term cyclosporine treatment to control psoriasis-related events during efalizumab therapy.

Costanzo A, Talamonti M, Spallone G, Botti E, Chimenti MS, Papoutsaki M, Chimenti S. Costanzo A, et al. Among authors: papoutsaki m. Dermatology. 2009;218(2):146-50. doi: 10.1159/000168086. Epub 2008 Oct 30. Dermatology. 2009. PMID: 18971577

7

Treatment of psoriasis and psoriatic arthritis.

Papoutsaki M, Costanzo A. Papoutsaki M, et al. BioDrugs. 2013 Jan;27 Suppl 1:3-12. doi: 10.1007/BF03325637. BioDrugs. 2013. PMID: 23990277 Review.

8

Infliximab in psoriasis and psoriatic arthritis.

Papoutsaki M, Osório F, Morais P, Torres T, Magina S, Chimenti S, Costanzo A. Papoutsaki M, et al. BioDrugs. 2013 Jan;27 Suppl 1:13-23. doi: 10.1007/BF03325638. BioDrugs. 2013. PMID: 23990278 Review.

9

Treatment of erythrodermic psoriasis with etanercept.

Esposito M, Mazzotta A, de Felice C, Papoutsaki M, Chimenti S. Esposito M, et al. Among authors: papoutsaki m. Br J Dermatol. 2006 Jul;155(1):156-9. doi: 10.1111/j.1365-2133.2006.07217.x. Br J Dermatol. 2006. PMID: 16792768 Clinical Trial.

10

Radiologically significant joint improvement in a patient affected by psoriatic arthritis treated with adalimumab.

Chimenti MS, Papoutsaki M, Teoli M, Zangrilli A, Perricone R, Chimenti S. Chimenti MS, et al. Among authors: papoutsaki m. Clin Exp Rheumatol. 2009 Nov-Dec;27(6):1056. Clin Exp Rheumatol. 2009. PMID: 20149332 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

52 results

Search Page

Filters